A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase ≤2 upper limit of normal
A model to predict antiviral treatment in HBeAg negative chronic hepatitis B with alanine aminotransferase ≤2 upper limit of normal
复制标题
DOI：
10.1111/liv.12344
复制
发表时间：
2014-08-01
影响因子：
6.7
通讯作者：
Wang, Kai
中科院分区：
文献类型：
--
作者：
Gao, Shuai;Fan, Yu-Chen;Wang, Kai
背景和目标：血清丙氨酸氨基转移酶（ALT）≥ 2000 IU/ml且ALT ≥ 2000 IU/ml的HBeAg阴性慢性B型肝炎（CH B）患者，肝组织学检查对预测抗病毒治疗至关重要
Background & Aims: Liver histological assessment is essential for predicting antiviral therapy in HBeAg negative chronic hepatitis B (CHB) patients with serum alanine aminotransferase (ALT) = 2000 IU/ml and ALT